Search research articles
Contact Us
Filters
Showing results (251-260 of 436) with videos related to
Page
of 44
Sort By:
Gastroenterology
|
June 1, 1993
Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor
Y Ilan, A Nagler, R Adler, et al.
Leukemia & Lymphoma
|
October 1, 1995
Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation
A Nagler, V R Deutsch, G Varadi, et al.
Harefuah
|
July 26, 2000
[Autologous stem cell transplantation breast cancer with distant metastases]
R Ben-Yosef, R Or, E Naparstek, et al.
Journal of Community Health
|
August 1, 1994
Health care reform as perceived by first year medical students
M S Wilkes, S A Skootsky, C S Hodgson, et al.
Clinical and Experimental Immunology
|
June 1, 1997
Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions
B L Shirkey, S Slavin, B P Vistica, et al.
Experimental Hematology
|
November 1, 1995
Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro
A Nagler, A Eldor, E Naparstek, et al.
Harefuah
|
August 1, 1975
[Aplastic anemia following acute viral hepatitis associated with hypogammaglobulinemia--attempted treatment by bone marrow transplantation]
A Eldor, R P Gale, H Brautbar, et al.
Cancer
|
October 1, 1992
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation
P E Drakos, A Nagler, R Or, et al.
Bone Marrow Transplantation
|
April 5, 2005
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide
M Bitan, R Or, M Y Shapira, et al.
Bone Marrow Transplantation
|
July 25, 2006
Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
E Hirshfeld, L Weiss, J Kasir, et al.
Page
of 44
Search research articles
Search
Showing results (251-260 of 436) with videos related to
Sort By:
Page
of 44
Gastroenterology
|
June 1, 1993
Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor
Y Ilan, A Nagler, R Adler, et al.
Leukemia & Lymphoma
|
October 1, 1995
Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation
A Nagler, V R Deutsch, G Varadi, et al.
Harefuah
|
July 26, 2000
[Autologous stem cell transplantation breast cancer with distant metastases]
R Ben-Yosef, R Or, E Naparstek, et al.
Journal of Community Health
|
August 1, 1994
Health care reform as perceived by first year medical students
M S Wilkes, S A Skootsky, C S Hodgson, et al.
Clinical and Experimental Immunology
|
June 1, 1997
Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions
B L Shirkey, S Slavin, B P Vistica, et al.
Experimental Hematology
|
November 1, 1995
Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro
A Nagler, A Eldor, E Naparstek, et al.
Harefuah
|
August 1, 1975
[Aplastic anemia following acute viral hepatitis associated with hypogammaglobulinemia--attempted treatment by bone marrow transplantation]
A Eldor, R P Gale, H Brautbar, et al.
Cancer
|
October 1, 1992
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation
P E Drakos, A Nagler, R Or, et al.
Bone Marrow Transplantation
|
April 5, 2005
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide
M Bitan, R Or, M Y Shapira, et al.
Bone Marrow Transplantation
|
July 25, 2006
Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
E Hirshfeld, L Weiss, J Kasir, et al.
Page
of 44